British Journal of Cancer · 2013 · 41 citations · 34 references
MedicineOncologyPathologyGastrointestinal OncologyMetastasisMolecular OncologyCancer Molecular PathologyCancer ProgressionColorectal CancerMalignant NeoplasmsMolecular Tumor ProfilingSignal Transduction In CancerColorectal Cancer PrognosisEpithelial-mesenchymal Transition In CancerEpithelial-mesenchymal Transition MarkersExtracellular Signal-regulated Kinase PathwayKinase Inhibitor ProteinsNf-κb SignalingProtein Expression BiomarkersVascular Invasion Assessment
BACKGROUND: This study evaluates the geographic expression pattern of Raf-1 Kinase Inhibitor Protein (RKIP) in colorectal cancer (CRC) in correlation with clinicopathological and molecular features, markers of epithelial-mesenchymal transition (EMT) and survival outcome. METHODS: Whole-tissue sections of 220 well-characterised CRCs were immunostained for RKIP. NF-κB and E-Cadherin expression was assessed using a matched multi-punch tissue microarray. Analysis of mismatch repair (MMR) protein expression, B-Raf and KRAS mutations was performed. RKIP expression in normal mucosa, tumour centre, invasion front and tumour buds was each assessed for clinical relevance. RESULTS: RKIP was diffusely expressed in normal mucosa and progressively lost towards tumour centre and front (P<0.0001). Only 0.9% of tumour buds were RKIP-positive. In the tumour centre, RKIP deficiency predicted metastatic disease (P=0.0307), vascular invasion (P=0.0506), tumour budding (P=0.0112) and an invasive border configuration (P=0.0084). Loss of RKIP correlated with NF-κB activation (P=0.0002) and loss of E-Cadherin (P<0.0001). Absence of RKIP was more common in MMR-deficient cancers (P=0.0191), while no impact of KRAS and B-Raf mutation was observed. RKIP in the tumour centre was identified as a strong prognostic indicator (HR (95% CI): 2.13 (1.27-3.56); P=0.0042) independently of TNM classification and therapy (P=0.0474). CONCLUSION: The clinical relevance of RKIP expression as an independent prognostic factor is restricted to the tumour centre. Loss of RKIP predicts features of EMT and correlates with frequent distant metastasis.
34
REporting recommendations for tumour MARKer prognostic studies (REMARK)
Lisa M. McShane, Douglas G. Altman, Willi Sauerbrei et al. · British Journal of Cancer · 2005 · 1.4K citations · Full text
Medicine, Biostatistics, Oncology +10
Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP
Kam C. Yeung, Thomas Seitz, Shengfeng Li et al. · Nature · 1999 · 923 citations
Stabilization of Snail by NF-κB Is Required for Inflammation-Induced Cell Migration and Invasion
Yadi Wu, Jiong Deng, Piotr Rychahou et al. · Cancer Cell · 2009 · 793 citations · Full text
The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases
Jeremy R. Jass, Wendy Atkin, J. Cuzick et al. · Histopathology · 1986 · 543 citations